Lintuzumab Ac-225
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lintuzumab Ac-225, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Testing an Anti-cancer Radio-Active Immunotherapy Called Lintuzumab Ac225 in Patients With High-Risk Myelodysplastic Syndrome That Has Not Responded to Other Treatment [Phase 1]